Old Web
English
Sign In
Acemap
>
authorDetail
>
Donald B. Axworthy
Donald B. Axworthy
Lymphoma
Monoclonal antibody
Radioimmunotherapy
Molecular biology
Bone marrow
3
Papers
119
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparison of Biodistributions and Therapeutic Efficacies of Pretargeted Radioimmunoconjugates Targeting the CD20, CD22, and DR Molecules on Human B Cell Lymphomas.
2005
Blood
Anastasia Pantelias
John M. Pagel
Nathan Hedin
Yukang Lin
Donald B. Axworthy
Louis J. Theodore
Oliver W. Press
Show All
Source
Cite
Save
Citations (0)
Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts
2003
Proceedings of the National Academy of Sciences of the United States of America
Meili Zhang
Zhuo Zhang
Kayhan Garmestani
Jody Schultz
Donald B. Axworthy
Carolyn K. Goldman
Martin W. Brechbiel
Jorge A. Carrasquillo
Thomas A. Waldmann
Show All
Source
Cite
Save
Citations (103)
Simplified Preformed Chelate Protein Radiolabeling with Technetium-99m Mercaptoacetamidoadipoylglycylglycine (N3S-Adipate)
1998
Bioconjugate Chemistry
Sudhakar Kasina
James Sanderson
Jeffrey N. Fitzner
Ananthachari Srinivasan
T.N. Rao
Lori J. Hobson
John M. Reno
Donald B. Axworthy
Paul L. Beaumier
Alan R. Fritzberg
Show All
Source
Cite
Save
Citations (16)
1